| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 29, 2023 | BSX Boston Scientific Corp | Mirviss Jeffrey B.45 | EVP&Pres, Periph Intervent | Sell | 18,628 | $53.48 | $996,229.63 | -12.9% | +1.8% | +45.4% | |
| Aug 28, 2023 | ATR Aptargroup, Inc. | Fotiades George L46 | Director | Sell | 9,500 | $128.46 | $1,220,333.15 | -48.2% | -1.9% | +16.8% | |
| Aug 28, 2023 | SRTS Sensus Healthcare, Inc. | Sardano Michael73 | President And General Counsel | Buy | 1,000 | $2.99 | $2,990.00 | +1.7% | -14.9% | +116.3% | |
| Aug 28, 2023 | ZBH Zimmer Biomet Holdings, Inc. | Hagemann Robert | Director | Buy | 2,000 | $116.48 | $232,960.00 | +100.0% | -3.1% | -2.4% | |
| Aug 28, 2023 | PODD Insulet Corp | Hollingshead James69 | President And CEO | Buy | 5,550 | $181.41 | $1,006,825.50 | +19.4% | +3.6% | +6.3% | |
| Aug 28, 2023 | ZBH Zimmer Biomet Holdings, Inc. | Begley Christopher B | Director | Buy | 1,000 | $117.11 | $117,114.00 | +39.4% | -3.1% | -2.4% | |
| Aug 28, 2023 | XAIR Beyond Air, Inc. | Carey Robert | Director | Buy | 250,000 | $2.70 | $673,750.00 | +25.6% | -42.8% | -84.3% | |
| Aug 28, 2023 | BDX Becton Dickinson & Co | Fraser Claire55 | Director | Sell | 848 | $281.66 | $238,847.68 | -3.8% | -14.9% | -14.2% | |
| Aug 28, 2023 | LFWD Lifeward Ltd. | Lind Global Fund II LP51 | - | Buy | 29,545 | $0.62 | $18,368.40 | +0.2% | +15.0% | -23.0% | |
| Aug 25, 2023 | BLFS Biolife Solutions Inc | Aebersold Sarah60 | Chief Human Resources Officer | Sell | 347 | $10.99 | $3,813.53 | -0.8% | +28.9% | +131.7% | |
| Aug 25, 2023 | BLFS Biolife Solutions Inc | Rice Michael72 | Chief Executive Officer | Sell | 1,729 | $10.99 | $19,001.71 | -0.4% | +28.9% | +131.7% | |
| Aug 25, 2023 | BLFS Biolife Solutions Inc | Foster Karen A.68 | Chief Quality Officer | Sell | 410 | $10.99 | $4,505.90 | -0.3% | +28.9% | +131.7% | |
| Aug 25, 2023 | BLFS Biolife Solutions Inc | Wichterman Troy60 | Chief Financial Officer | Sell | 585 | $10.99 | $6,429.15 | -0.9% | +28.9% | +131.7% | |
| Aug 25, 2023 | BLFS Biolife Solutions Inc | Berard Todd67 | Chief Marketing Officer | Sell | 347 | $10.99 | $3,813.53 | -0.3% | +28.9% | +131.7% | |
| Aug 25, 2023 | AVTR Avantor, Inc. | Vanderhaegen Frederic65 | EVP, Americas And Europe | Sell | 25,000 | $21.47 | $536,750.00 | -13.5% | -6.7% | +17.9% | |
| Aug 25, 2023 | BSX Boston Scientific Corp | Brown Vance R | SVP, GC And Corp. Secretary | Sell | 15,750 | $50.52 | $795,756.15 | -35.5% | +9.6% | +56.0% | |
| Aug 25, 2023 | BLFS Biolife Solutions Inc | Mathew Aby J.68 | EVP &Chief Scientific Officer | Sell | 519 | $10.99 | $5,703.81 | -0.2% | +28.9% | +131.7% | |
| Aug 25, 2023 | BLFS Biolife Solutions Inc | Phillips Geraint | SVP, Global Operations | Sell | 179 | $10.99 | $1,967.21 | -0.3% | +28.9% | +131.7% | |
| Aug 25, 2023 | BLFS Biolife Solutions Inc | Schulz Marcus71 | Chief Revenue Officer | Sell | 347 | $10.99 | $3,813.53 | -0.8% | +28.9% | +131.7% | |
| Aug 25, 2023 | ZBH Zimmer Biomet Holdings, Inc. | Michelson Michael W | Director | Buy | 1,300 | $115.50 | $150,150.00 | +62.4% | -1.6% | -0.2% | |
| Aug 25, 2023 | STXS Stereotaxis, Inc. | Isaac Paul J78 | Director, See Remarks | Buy | 9,000 | $1.74 | $15,670.00 | +0.2% | +1.8% | +38.0% | |
| Aug 25, 2023 | RXST Rxsight, Inc. | Tammenoms Bakker Juliet | Director | Sell | 16,208 | $29.25 | $474,129.38 | -23.4% | -0.4% | +91.4% | |
| Aug 25, 2023 | LFWD Lifeward Ltd. | Lawless Michael A | Chief Financial Officer | Buy | 15,051 | $0.62 | $9,280.60 | +99.3% | +16.3% | -21.4% | |
| Aug 25, 2023 | INFU Infusystem Holdings, Inc | Malhotra R. Rimmy72 | Director | Sell | 20,000 | $10.49 | $209,802.00 | -8.3% | -3.1% | -34.4% | |
| Aug 25, 2023 | ZBH Zimmer Biomet Holdings, Inc. | Bernard Betsy J | Director | Buy | 1,021 | $114.40 | $116,805.51 | +23.2% | -1.6% | -0.2% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.